Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Rathmann: Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004. (0.09 sec) 

Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994- …

- diabetesjournals.org
W Rathmann, B Haastert, A Icks, G Giani - Diabetes care, 2007 - Am Diabetes Assoc
RESULTS—Mean annual total prescription costs per diabetic patient were €559 in 2004 (€372
in 1994), equaling a 60% (standardized) increase (P < 0.01). Average costs for antidiabetic medication
were €172 in 2004, a 100% increase (P < 0.01). The major antidiabetic cost factor was ...
Cited by 11 - Related articles - BL Direct - All 5 versions

Direct costs and health-related resource utilisation in the 6 months after insulin …


A Liebl, L Breitscheidel, C Nicolay, M … - … Medical Research and …, 2008 - informahealthcare.com
Results: The percentage of patients using blood glucose monitoring increased from 76.4 to
99.6%; 42.1% of patients remained on oral anti-diabetic medication, with metformin used most
frequently (36.5%). Total average cost of resource use related to diabetes care per patient ...
Cited by 3 - Related articles - All 6 versions

[PDF] Trends in Outpatient Prescription Drug Costs in Diabetic Patients in Germany


W Rathmann, B Haastert, A Icks, G Giani - Diabetes Care, 2007 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS — A total of 46,017 diabetic patients and 46,017 age-
and sex-matched control subjects in 400 nationwide practices (2004) were com- pared with 29,956
diabetic patients and 13,226 control subjects (361 practices) in 1994 (data from IMS ...
Related articles

Costs of diabetes mellitus type 2 and self measurement of blood glucose in …


C Weber, K Neeser, H Wenzel, B … - … von Verband der …, 2006 - ncbi.nlm.nih.gov
It is extremely difficult to assess the prevalence and the total costs of diabetes mellitus for the
German health care system. The last sound assessment of the total costs is based on the
CODE-2 study, although this study reflects the situation in 1998. METHODS: In this paper ...
Cited by 4 - Related articles

[CITATION] Politisches Aktionsprogramm der Kassenärzte


K Bundesvereinigung - 2006
Cited by 4 - Related articles

The cost burden of diabetes mellitus: the evidence from Germany—the CoDiM …


I Köster, L von Ferber, P Ihle, I Schubert, H Hauner - Diabetologia, 2006 - Springer
Abstract Aims/hypothesis: The aim of this study was to identify the health care costs of diabetic
patients in Germany in 2001, focusing on the influence of age, sex, and type of treatment. Subjects
and methods: Annual direct costs of medical care and indirect costs of inability to work ...
Cited by 44 - Related articles - BL Direct - All 4 versions

Diabetes-prevalence and cost of illness in Germany: a study evaluating data from …


SA Stock, M Redaelli, G Wendland, D Civello, … - Diabetic …, 2006 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 29 - Related articles - BL Direct - All 4 versions

[PDF] Direct Cost of Ambulatory Care of Type 2 Diabetes in the Middle and High Income …


A Kumar, J Nagpal, A Bhartia - JAPI, 2008 - japi.org
Abstract Objective : To estimate the direct cost of ambulatory care in diabetes patients in the middle
and high income group populace of Delhi. Research Design and Methods : We analyzed the
drugs, investigations, consultation and monitoring related data available from a survey of ...
Related articles - View as HTML - All 4 versions

Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of …


WA Scherbaum, G Goodall, KM Erny- … - Cost Effectiveness …, 2009 - resource-allocation.com
Over patient lifetimes pioglitazone treatment improved undiscounted life expectancy by 0.406
years and improved quality-adjusted life expectancy by 0.120 quality-adjusted life years
(QALYs) compared to placebo. Direct medical costs (treatment plus complication costs) ...
Related articles - Cached - All 8 versions

An economic evaluation of anticipated costs and savings of a behavior change …


PN Wiegand, AI Wertheimer - Pharmacy Practice (Internet), 2008 - SciELO Brasil
SciELO - Scientific Electronic Library Online Browse SciELO, SciELO Library Error Detector An
unexpected error occurred in SciELO servers. Click on the SciELO logo to browse the SciELO
Library or use the browser "BACK" button to return to the previous page. ...
Related articles - Cached - All 10 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google